PATLY.AIApplication
19249611 · ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS
Filed 2025-06-25 · Pending The official file ↗ · Art unit OPAP · Examiner Docket Central Easy · CPC A61K 31/506 · ACLARIS THERAPEUTICS, INC. · DLA Piper LLP (US)/Pittsburgh
Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read